MX9302951A - Composicion farmaceutica para tratar la hiperproliferacion celular. - Google Patents

Composicion farmaceutica para tratar la hiperproliferacion celular.

Info

Publication number
MX9302951A
MX9302951A MX9302951A MX9302951A MX9302951A MX 9302951 A MX9302951 A MX 9302951A MX 9302951 A MX9302951 A MX 9302951A MX 9302951 A MX9302951 A MX 9302951A MX 9302951 A MX9302951 A MX 9302951A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
cell hyperproliferation
treat cell
hyperproliferation
treat
Prior art date
Application number
MX9302951A
Other languages
English (en)
Inventor
Ben Y Tseng
Kevin D Cooper
Craig Hammerberg
Kameron W Maxwell
Original Assignee
Genta Inc
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genta Inc, Univ Michigan filed Critical Genta Inc
Publication of MX9302951A publication Critical patent/MX9302951A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/312—Phosphonates
    • C12N2310/3125—Methylphosphonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Se proporcionan métodos para tratar trastornos o condiciones caracterizadas por hiperproliferación celular utilizando compuestos inhibidores de interleucina-1 y compuestos útiles en los métodos descritos.
MX9302951A 1992-05-22 1993-05-20 Composicion farmaceutica para tratar la hiperproliferacion celular. MX9302951A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88773492A 1992-05-22 1992-05-22

Publications (1)

Publication Number Publication Date
MX9302951A true MX9302951A (es) 1994-07-29

Family

ID=25391751

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302951A MX9302951A (es) 1992-05-22 1993-05-20 Composicion farmaceutica para tratar la hiperproliferacion celular.

Country Status (9)

Country Link
EP (1) EP0644765A4 (es)
JP (1) JPH07508977A (es)
KR (1) KR950701528A (es)
AU (1) AU4388993A (es)
CA (1) CA2136349A1 (es)
IL (1) IL105741A0 (es)
MX (1) MX9302951A (es)
NZ (1) NZ253509A (es)
WO (1) WO1993024134A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
GB9405021D0 (en) * 1994-03-15 1994-04-27 Unilever Plc Skin treatment composition
DK0883687T3 (da) * 1996-03-01 2005-03-07 Euroscreen Sa C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
HUP0004089A2 (hu) * 1997-07-10 2001-04-28 Therakos, Inc. A bél és a húgyhólyag gyulladásos rendellenességeinek kezelése testen kívüli fotoferezissel
WO2004100987A2 (en) * 2003-05-06 2004-11-25 Regeneron Pharmaceuticals, Inc. Methods of using il-1 antagonists to treat neointimal hyperplasia
US7960355B2 (en) 2003-05-23 2011-06-14 Isis Pharmaceuticals, Inc. Compositions and methods for the modulation of the expression of B7 protein
US7897582B2 (en) 2003-05-23 2011-03-01 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
WO2006084145A2 (en) * 2005-02-02 2006-08-10 Regeneron Pharmaceuticals, Inc. Methods of using il-1 antagonists to reduce c-reactive protein
GB0607189D0 (en) * 2006-04-10 2006-05-17 Polybiomed Ltd interleukin IL 1ra composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006702A1 (en) * 1988-01-21 1989-07-27 Chemex Pharmaceuticals, Inc. Selective inhibition of gene expression by photoactivatable oligonucleotides
CA2080336A1 (en) * 1990-04-09 1991-10-10 Jeanette A. M. Maier Rejuvenation compositions and methods for their use
US5135917A (en) * 1990-07-12 1992-08-04 Nova Pharmaceutical Corporation Interleukin receptor expression inhibiting antisense oligonucleotides
EP0587749A4 (en) * 1991-05-31 1995-08-30 Genta Inc Compositions and delivery systems for transdermal administration of neutral oligomers
AU657701B2 (en) * 1991-08-30 1995-03-23 Vertex Pharmaceuticals Incorporated Interleukin 1beta protease and interleukin 1beta protease inhibitors

Also Published As

Publication number Publication date
JPH07508977A (ja) 1995-10-05
WO1993024134A1 (en) 1993-12-09
IL105741A0 (en) 1993-09-22
EP0644765A4 (en) 1997-02-26
NZ253509A (en) 1999-09-29
AU4388993A (en) 1993-12-30
EP0644765A1 (en) 1995-03-29
CA2136349A1 (en) 1993-12-09
KR950701528A (ko) 1995-04-28

Similar Documents

Publication Publication Date Title
ES2194106T3 (es) .ompuestos de imidazol
MX9300766A (es) Piridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
ES2196082T3 (es) Analagos del factor de crecimiento de queratinocitos.
AR024138A1 (es) Inhibidores de la proliferacion celular
BR8904519A (pt) Composicao fungicida,processos para preparar compostos fungicidas e para preparar compostos de benzoilacetonitrila
MX9302951A (es) Composicion farmaceutica para tratar la hiperproliferacion celular.
ES518876A0 (es) Proceso para el tratamiento de residuos urbanos e instalacion para su realizacion
MX9203092A (es) Composicion anestesica y metodo para su uso.
AR240975A1 (es) Composicion para tratamiento de plantas
IT1205715B (it) Derivati di piroglutammide,agenti nootropici che li contengono e procedimento per la loro preparazione
ES505321A0 (es) Procedimiento para la desintegracion de derivados de 6-amino-5-triacina,contenidos en aguas residuales
ES2032922T3 (es) Empleo de los paf-aceter antagonicos para la fabricacion de un medicamento y procedimiento para determinar la eficacia de los mismos.
ES525297A0 (es) Procedimiento para la obtencion de derivados de terc.-butanol sustituidos
BR8801117A (pt) Composto,processo para sua obtencao,composicao para o combate de doencas em plantas,utilizacao e cultura
ATE40116T1 (de) 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva.
ES518877A0 (es) Perfeccionamientos en las plantas para la incineracion de basuras.
ITRM920305A1 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
ES542274A0 (es) Procedimiento y disposicion para el tratamiento de papelote
IT1147730B (it) Procedimento per il trattamento preventilo nella fabbricazione di acciaio non stagnato
ES495830A0 (es) Perfeccionamientos en valvulas de descarga para instalacion hidraulica
ES543582A0 (es) Perfeccionamientos en los batanes para el tratamiento de pieles y similares
ES1010158Y (es) Dispositivo para la manipulacion de perfiles en instalaciones para tratamiento de los mismos.
ES521091A0 (es) Mejoras en el objeto de la patente principal no 513.956 por procedimiento para la carbonilacion de olefinas y esteres organicos.
ES264767Y (es) Lama perfeccionada para puertas enrollables.
ES538296A0 (es) Procedimiento para la fabricacion de cianuros inorganicos en comprimidos